TransMedics Group Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 38.8% | 41.0% | 38.2% | 39.5% | 44.1% | 40.8% | 38.5% | 38.6% | 41.2% | 41.9% | 41.8% | 40.4% | 41.3% | |
| 61.2% | 59.0% | 61.8% | 60.5% | 55.9% | 59.2% | 61.5% | 61.4% | 58.8% | 58.1% | 58.2% | 59.6% | 58.7% | |
| 57.7% | 13.3% | 11.8% | 12.1% | 13.1% | 13.5% | 12.0% | 10.1% | 10.6% | 12.9% | 14.3% | 16.7% | 13.8% | |
| 46.1% | 42.6% | 37.3% | 37.5% | 39.2% | 38.6% | 30.4% | 28.0% | 31.2% | 31.2% | 32.0% | 28.2% | 30.6% | |
| 103.9% | 55.8% | 49.0% | 49.6% | 52.3% | 52.1% | 42.3% | 38.1% | 42.6% | 44.9% | 50.5% | 47.1% | 46.5% | |
| -42.7% | 3.2% | 12.8% | 10.9% | 3.6% | 7.1% | 19.1% | 23.2% | 16.2% | 13.2% | 7.6% | 12.5% | 12.2% | |
| 5.4% | 4.4% | 3.7% | 3.2% | 3.3% | 2.9% | 2.4% | 2.2% | 2.4% | 2.1% | 4.1% | 3.8% | 3.2% | |
| -40.5% | 4.8% | 12.8% | 10.6% | 3.9% | 5.7% | 18.6% | 23.0% | 16.0% | 13.5% | 4.9% | 10.2% | 10.9% | |
| -2.3% | -0.2% | 0.2% | 0.0% | 0.0% | 0.1% | 0.7% | 0.8% | -0.9% | -52.1% | 0.7% | 2.5% | -11.8% | |
| -38.3% | 5.0% | 12.6% | 10.7% | 3.9% | 5.6% | 17.9% | 22.2% | 16.9% | 65.6% | 4.2% | 7.7% | 22.7% | |
| -32.3% | 13.6% | 21.1% | 17.8% | 12.0% | 13.4% | 25.3% | 29.5% | 23.2% | 20.2% | 15.8% | 14.0% | 17.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.